CIBEST:BVCGrupo Cibest S.A. Analysis
Data as of 2026-06-16 - not real-time
COP 82,500.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Current market pricing places CIBEST at 82,500 COP, comfortably above its 20‑day (75,172 COP) and 50‑day (79,162 COP) SMAs and even the 200‑day SMA (72,529 COP), indicating a short‑term bullish bias. However, the RSI of 70.6 signals an overbought condition, and the price sits just below the identified resistance of 84,900 COP, suggesting limited upside in the immediate term. Technical momentum remains positive with a bullish MACD histogram (+1,130) and a strong dividend yield of 5.31% supported by a low payout ratio (16%). Fundamentally, the stock trades at a PE of 11.9, well below the industry average of 16.9, and a PB of 2.15, implying relative undervaluation, while the ROE of 16.9% and operating margin of 36% demonstrate solid profitability. The balance sheet shows ample cash (55,665 bn COP) against debt (26,144 bn COP) and a low beta of 0.56, indicating limited market volatility exposure, though 30‑day price volatility is high at 40%.
The Q1 2026 earnings release disclosed a 16% headline net‑income decline due to a one‑off wealth‑tax accrual, yet normalized earnings rose, reflecting underlying business strength. Management highlighted rising net‑interest margins and loan growth amid Colombia’s tighter monetary policy, a new share‑buyback program, and continued digital platform expansion, all of which should bolster medium‑term earnings. Risks include elevated sector and geographic concentration in Colombia, medium regulatory risk from tax policy, and decreasing volume trends that could affect liquidity. Overall, the stock offers an attractive dividend and solid fundamentals but faces short‑term technical overextension and earnings pressure.
The Q1 2026 earnings release disclosed a 16% headline net‑income decline due to a one‑off wealth‑tax accrual, yet normalized earnings rose, reflecting underlying business strength. Management highlighted rising net‑interest margins and loan growth amid Colombia’s tighter monetary policy, a new share‑buyback program, and continued digital platform expansion, all of which should bolster medium‑term earnings. Risks include elevated sector and geographic concentration in Colombia, medium regulatory risk from tax policy, and decreasing volume trends that could affect liquidity. Overall, the stock offers an attractive dividend and solid fundamentals but faces short‑term technical overextension and earnings pressure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in overbought territory
- Price approaching resistance at 84,900 COP
- Recent earnings dip due to wealth‑tax accrual
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Rising net‑interest margins and loan growth
- Attractive 5.31% dividend yield with low payout ratio
- Undervalued PE relative to industry peers
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustainable dividend and strong ROE
- Low beta indicating defensive profile
- Continued digital platform expansion and share‑buyback support
Key Metrics & Analysis
Financial Health
Revenue Growth10.80%
Profit Margin14.68%
P/E Ratio11.9
ROE16.93%
ROA1.78%
P/B Ratio2.2
Op. Cash FlowCOP-23137215315968
Industry P/E16.9
Technical Analysis
TrendNeutral
RSI70.6
SupportCOP 70,120.00
ResistanceCOP 84,900.00
MA 20COP 75,172.00
MA 50COP 79,162.40
MA 200COP 72,528.70
MACDBullish
VolumeDecreasing
Fear & Greed Index92.5
Valuation
Target PriceCOP 62,009.13
Upside/Downside-24.84%
GradeFair
TypeBlend
Dividend Yield5.31%
Risk Assessment
Beta0.56
Volatility40.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.